NEIMETH INTERNATIONAL PHARMACEUTICAL PLC. (NEIMETH) recently released its first-half financial results (year-end is September), posting revenue growth of 19.38% to NGN1.17bn from NGN975.98mn in H1:2019. Revenue from both business lines edged higher, especially the Animal Health segment, which surged by 897.42% YoY to NGN182.94mn from NGN18.34mn in the corresponding period last year.
Click on the link below to download the full report:
Earnings Update- NEIMETH H1-2020
